News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major news items published in the past hour.
  • No significant economic releases or central-bank comments occurred.
  • No major corporate earnings, deals, or guidance updates reported.
  • No new geopolitical events emerged to shift risk sentiment.
  • Markets traded largely without headline-driven moves during the hour.
  • Trading volume and volatility remained subdued amid limited headlines.

Latest Articles

Lumentum Is Overpriced for Perfection - Fade the Post-Quarter Euphoria

Lumentum Is Overpriced for Perfection - Fade the Post-Quarter Euphoria

Lumentum (LITE) trades at nosebleed multiples - PE ~145, EV/EBITDA ~103, and price-to-free-cash-flow ~560x - pricing flawless execution and sustained hypergrowth. Recent earnings and guidance (market reaction) suggest demand variability and margin sensitivity; that combination creates a high-reward trade to fade optimism. Short at $945.41, stop $1,…

Netflix: Underpriced Optionality on 2027 Earnings Rebound

Netflix: Underpriced Optionality on 2027 Earnings Rebound

Netflix is positioned to convert structural subscriber upside and improve margins through its ad-tier rollout, password-sharing monetization, and content spending normalization. We argue the market is underestimating 2027 earnings power. Trade plan: enter $520.00, stop $460.00, target $650.00 over a 180 trading-day horizon.

Bicara Therapeutics: Buying the Clinical Story as Data and Cash Align

Bicara Therapeutics: Buying the Clinical Story as Data and Cash Align

Bicara (BCAX) is a clinical-stage oncology name with encouraging Phase 1b signals for its lead bifunctional antibody and a freshly replenished war chest after an oversubscribed offering. Technicals and short-interest create near-term noise, but the combination of strong response data, $172.5M+ of gross proceeds and a sub-$2B market cap make a long …

Richardson Electronics to Present at the 17th Annual Midwest IDEAS Investor Conference on August 26th

Richardson Electronics to Present at the 17th Annual Midwest IDEAS Investor Conference on August 26th

Richardson Electronics, Ltd., a global provider of engineered solutions for green energy, power management, and custom display markets, announced it will present at the 17th Annual Midwest IDEAS Investor Conference on August 26, 2026. Key executives will deliver a formal presentation and host one-on-one investor meetings, showcasing the company's o…

Ellsworth Growth and Income Fund Ltd. Increases Quarterly Distribution 16% to $0.22 Per Share From $0.19 Per Share

Ellsworth Growth and Income Fund Ltd. Increases Quarterly Distribution 16% to $0.22 Per Share From $0.19 Per Share

Ellsworth Growth and Income Fund Ltd. announced a 16% increase in its quarterly cash distribution to $0.22 per share, up from $0.19. The Fund aims to maintain an annual distribution of at least 5% of its trailing 12-month average market price and is managed to balance income and capital appreciation over the long-term, primarily investing in conver…

Buy the Backlog, Buy the Pullback: RTX After Q2 Needs Patience

Buy the Backlog, Buy the Pullback: RTX After Q2 Needs Patience

RTX's Q2 profile centers on a $289 billion backlog that provides multi-year revenue visibility and defense cashflow resilience. That strength supports a constructive long idea, but the stock's valuation and exposure to cyclical commercial aerospace demand mean the trade is best sized as a patient, pullback-driven long with a clearly defined stop.

BETR: Speculative Mid-Term Long — Execution Risk Demands Tight Stops

BETR: Speculative Mid-Term Long — Execution Risk Demands Tight Stops

Better Home & Finance (BETR) remains a story stock with real product wins — warehouse lines, Fannie/Coinbase programs — but recent misses, a CEO shakeup and large negative cash flow make this a binary setup. For nimble traders willing to take concentrated risk, a disciplined mid-term long with a tight stop offers asymmetric upside if management sta…

Diamondback (FANG): Permian Leverage, Clean FCF and a Tactical Long

Diamondback (FANG): Permian Leverage, Clean FCF and a Tactical Long

Diamondback Energy offers concentrated Permian exposure, robust free cash flow ($3.68B) and a conservative balance sheet (debt/equity 0.33). Valuation is mixed — a premium P/E (~38x) versus attractive EV/EBITDA (~6.1x) — making this a tactical long for investors who want oil upside with operational resilience. Trade plan: enter at $200.53, target $…

Splash Beverage Group to Rebrand as Endovia Health Sciences

Splash Beverage Group to Rebrand as Endovia Health Sciences

Splash Beverage Group, Inc. is rebranding as Endovia Health Sciences, Inc. reflecting a strategic transformation from a beverage company to a diversified cannabinoid health sciences platform. The company plans to commercialize pharmaceutical cannabinoid assets, develop FDA-regulated human and veterinary therapeutics, and expand cannabinoid wellness…

Verizon Simplicity meets Google AI: Preorder the Pixel 11 series today

Verizon Simplicity meets Google AI: Preorder the Pixel 11 series today

Verizon has opened preorders for the Google Pixel 11 series including Pixel 11, Pixel 11 Pro, Pixel 11 Pro XL, Pixel 11 Pro Fold, and Pixel Watch 5 through its new simplified Simplicity Plans. The offerings include multiple cost-effective financing options, aggressive trade-in credits, and upgrades every year. The partnership leverages Verizon's ne…